{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:27:54Z","timestamp":1791912474644,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13268-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:16:21Z","timestamp":1779264981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Breakthrough serogroup Y meningococcal disease in a vaccinated patient with myasthenia gravis receiving ravulizumab: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Silvija \u0160oprek","family":"Strugar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa\u0161ko","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Buti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branimir","family":"Gjura\u0161in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kutle\u0161a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"10","key":"13268_CR1","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.cmi.2021.06.030","volume":"27","author":"CCM Schaap","year":"2021","unstructured":"Schaap CCM, Grotens A, De Haan AFJ, Blijlevens NMA, Langemeijer SMC. Infections during eculizumab therapy in a Dutch population of patients with paroxysmal nocturnal haemoglobinuria. Clin Microbiol Infect. 2021;27(10):1534\u20136. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.030.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"13268_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/cmr.4.3.359","volume":"4","author":"JE Figueroa","year":"1991","unstructured":"Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4(3):359\u201395. https:\/\/doi.org\/10.1128\/cmr.4.3.359.","journal-title":"Clin Microbiol Rev"},{"key":"13268_CR3","unstructured":"UK Health Security Agency. Meningococcal ACWY (MenACWY) programme: information for healthcare professionals [Internet]. London: UKHSA; [cited 2026 Feb 17]. Available from: https:\/\/www.gov.uk\/government\/publications\/menacwy-programme-information-for-healthcare-professionals\/meningococcal-acwy-programme-information-for-healthcare-professionals"},{"issue":"4","key":"13268_CR4","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","volume":"39","author":"CE Corless","year":"2001","unstructured":"Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, et al. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39(4):1553\u20138. https:\/\/doi.org\/10.1128\/JCM.39.4.1553-1558.2001.","journal-title":"J Clin Microbiol"},{"key":"13268_CR5","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. 2025. https:\/\/www.eucast.org"},{"key":"13268_CR6","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3390\/antibiotics11121843","volume":"11","author":"N Haddad","year":"2022","unstructured":"Haddad N, Carr M, Balian S, Lannin J, Kim Y, Toth C, et al. The blood\u2013brain barrier and pharmacokinetic\/pharmacodynamic optimization of antibiotics for the treatment of central nervous system infections in adults. Antibiot (Basel). 2022;11:1843. https:\/\/doi.org\/10.3390\/antibiotics11121843.","journal-title":"Antibiot (Basel)"},{"key":"13268_CR7","volume-title":"Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management","author":"National Institute for Health and Care Excellence (NICE)","year":"2024","unstructured":"National Institute for Health and Care Excellence (NICE). Evidence review for antibiotics for bacterial meningitis. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. London: NICE; 2024."},{"key":"13268_CR8","unstructured":"European Medicines Agency. Ultomiris (ravulizumab): summary of product characteristics. Published online 2023."},{"issue":"4","key":"13268_CR9","doi-asserted-by":"publisher","first-page":"e0195909","DOI":"10.1371\/journal.pone.0195909","volume":"13","author":"D Sheridan","year":"2018","unstructured":"Sheridan D, Yu ZX, Zhang Y, Sun F, Lasaro MA, et al. Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action. PLoS ONE. 2018;13(4):e0195909. https:\/\/doi.org\/10.1371\/journal.pone.0195909.","journal-title":"PLoS ONE"},{"issue":"19","key":"13268_CR10","doi-asserted-by":"publisher","first-page":"9398","DOI":"10.3390\/ijms26199398","volume":"26","author":"C Skarlis","year":"2025","unstructured":"Skarlis C, Angelopoulou E, Rentzos M, Papageorgiou SG, Anagnostouli M. Monoclonal Antibodies as Therapeutic Agents in Autoimmune and Neurodegenerative Diseases of the Central Nervous System: Current Evidence on Molecular Mechanisms and Future Directions. Int J Mol Sci. 2025;26(19):9398. https:\/\/doi.org\/10.3390\/ijms26199398.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13268_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4161\/viru.26515","volume":"5","author":"LA Lewis","year":"2014","unstructured":"Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence. 2014;5(1):98\u2013126. https:\/\/doi.org\/10.4161\/viru.26515.","journal-title":"Virulence"},{"key":"13268_CR12","doi-asserted-by":"publisher","first-page":"1269325","DOI":"10.3389\/fimmu.2023.1269325","volume":"14","author":"N Galli","year":"2023","unstructured":"Galli N, Pettine L, Panigada M, Daprai L, Suriano, et al. G Non-capsulated Neisseria meningitidis sepsis in a paroxysmal nocturnal hemoglobinuria patient treated with ravulizumab: case report and review of the literature. Front Immunol. 2023;14:1269325. https:\/\/doi.org\/10.3389\/fimmu.2023.1269325.","journal-title":"Front Immunol"},{"issue":"27","key":"13268_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","volume":"66","author":"LA McNamara","year":"2017","unstructured":"McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017;66(27):734\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm6627e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"13268_CR14","doi-asserted-by":"publisher","first-page":"e0332073","DOI":"10.1371\/journal.pone.0332073","volume":"20","author":"C Carrillo Infante","year":"2025","unstructured":"Carrillo Infante C, Mujeebuddin A. Eculizumab and ravulizumab clinical trial and real-world pharmacovigilance of meningococcal infections across indications. PLoS ONE. 2025;20(9):e0332073. https:\/\/doi.org\/10.1371\/journal.pone.0332073.","journal-title":"PLoS ONE"},{"key":"13268_CR15","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: Annual epidemiological report for 2022 [Internet]. Stockholm: ECDC. 2024 [cited 2026 Feb 17]. Available from: https:\/\/www.ecdc.europa.eu"},{"key":"13268_CR16","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1017\/S0950268824001535","volume":"152","author":"MT Htar","year":"2024","unstructured":"Htar MT, Findlow J, Balmer P, Swerdlow DL. Global epidemiology of serogroup Y invasive meningococcal disease: a literature review. Epidemiol Infect. 2024;152:e157. https:\/\/doi.org\/10.1017\/S0950268824001535.","journal-title":"Epidemiol Infect"},{"key":"13268_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41479-019-0062-0","volume":"11","author":"C Feldman","year":"2019","unstructured":"Feldman C, Anderson RM. Meningococcal pneumonia: a review. Pneumonia (Nathan). 2019;11:3. https:\/\/doi.org\/10.1186\/s41479-019-0062-0.","journal-title":"Pneumonia (Nathan)"},{"issue":"9","key":"13268_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","volume":"69","author":"SA Mbaeyi","year":"2020","unstructured":"Mbaeyi SA, Bozio CH, Duffy J, Rubin LG, Hariri S, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1\u201341. https:\/\/doi.org\/10.15585\/mmwr.rr6909a1.","journal-title":"MMWR Recomm Rep"},{"key":"13268_CR19","unstructured":"Centers for Disease Control and Prevention. Meningococcal vaccine recommendations [Internet]. Atlanta (GA): CDC; [cited 2026 Feb 17]. Available from: https:\/\/www.cdc.gov\/meningococcal\/hcp\/vaccine-recommendations\/index.html"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13268-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:02:22Z","timestamp":1784044942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13268-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13268"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13268-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This case report was conducted in accordance with institutional and international ethical standards. According to local regulations, formal ethical approval is not required for anonymized case reports.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1332"}}